Try it
Ophthalmology · Glaucoma: netarsudil
Sample itemWhich antiglaucoma drug acts by Rho kinase inhibition, increasing trabecular outflow and reducing episcleral venous pressure?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Netarsudil
Netarsudil inhibits Rho kinase and the norepinephrine transporter, and acts on the trabecular pathway. Conjunctival hyperaemia and corneal verticillata are common side effects. It also lowers episcleral venous pressure, which other topical classes do not.
Option by option
A. Brinzolamide
Brinzolamide is a carbonic anhydrase inhibitor.
B. Bimatoprost
Bimatoprost is a prostamide that increases uveoscleral outflow.
C. Netarsudil (correct)
Correct. Netarsudil is a Rho kinase inhibitor.
D. Brimonidine
Brimonidine is an alpha-2 agonist.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Ophthalmology questions
- GlaucomaWhich topical glaucoma medicine lowers intraocular pressure mainly by increasing uveoscl…
- Ocular oncologyA 2-year-old child has a white pupillary reflex (leukocoria). The gene commonly involved…
- UveaA patient has a painful red eye with photophobia, ciliary congestion, a small irregular…
- GlaucomaWhich drug is given systemically to reduce intraocular pressure in acute angle-closure g…